Alcohol Dependence: Clinical Trials

307 trials for Alcohol Dependence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

237 completed, 25 unknown, 18 terminated, 12 recruiting. 92 Not applicable, 82 Phase 2, 50 Phase 3, 46 Phase 4, 24 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable92Completed 68, Unknown 9, Recruiting 6, Terminated 5, Not yet recruiting 2, Active not recruiting 1, Withdrawn 1
Phase 282Completed 67, Unknown 6, Terminated 4, Recruiting 2, Withdrawn 2, Enrolling by invitation 1
Phase 350Completed 40, Unknown 5, Withdrawn 4, Enrolling by invitation 1
Phase 446Completed 37, Terminated 7, Unknown 1, Withdrawn 1
Phase 124Completed 22, Recruiting 1, Withdrawn 1
Early Phase 13Completed 2, Unknown 1

Follow Alcohol Dependence: new trials by email Literature Review of Alcohol Dependence trials Research Report on Alcohol Dependence

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence
VR Cue-Exposure Including Olfactory Stimuli - Alcohol Dependence
Not applicableCompletedCharite University, Berlin, Germany202026-03-072026-10-20
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)
Deep TMS (DTMS), Sham (No Treatment) - Alcohol Use Disorder, Alcoholism
Not applicableRecruitingBrainsway1862025-11-072026-10-27
Can Selfcompassion Training Reduce Alcohol Consumption in Patients With Alcohol Use Disosrder ?
Mindful Self-Compassion program, Treatment As Usual (TAU) program - Addiction, Addiction Disorders
Not applicableNot yet recruitingEtablissement Public de Santé Barthélemy Durand1522025-10-012025-08-20
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
Psilocybin, Ketamine - Alcohol Use Disorder, Alcohol Dependence
Phase 2RecruitingUniversity of Iowa802025-06-122025-11-28
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Tirzepatide, Placebo - Alcohol Use Disorder, Alcohol Abuse/Dependence
Phase 2RecruitingAnders Fink-Jensen, MD, DMSci1082025-05-052026-02-10
Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study
Sham iTBS, Active iTBS, 10 Hz TMS - Alcohol Use Disorder, Alcohol Dependence
Not applicableCompletedWake Forest University Health Sciences52025-03-212026-10-16
The Impact of Heavy Alcohol Use on Saliva and Oral Health
Alcohol Use Disorder, Alcohol Dependence
RecruitingNational Institutes of Health Clinical Center (CC)722025-01-092026-08-28
Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
French version PAWSS - Addiction, Substance, Alcohol Use Disorder
RecruitingEtablissement Public de Santé Barthélemy Durand5452024-11-112025-02-25
A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.
Vivitrol Injectable Product, IVL3004, IVL4002 - Opioid Dependence, Alcohol Dependence
Phase 1RecruitingInventage Lab., Inc.402024-09-112025-09-15
Psilocybin-assisted Therapy for Alcohol Use Disorder
Psilocybin, Niacin - Alcohol Use Disorder, Alcohol Dependence
Phase 2UnknownUniversity of Sydney902024-09-012024-06-10
Virtual Incentive Treatment for Alcohol
Contingency Management, Computer Based Training for Cognitive Behavioral Therapy for AUD (CBT4CBT) - Alcohol Use Disorder, Alcohol Drinking
Not applicableRecruitingWashington State University2002024-06-182025-05-30
Tracking Mood: The Effects of Daily Mood Tracking VAS on Alcohol Consumption in Adult Heavy Drinkers
Intervention - Alcohol Abuse, Alcohol Drinking
Not applicableUnknownIlona Myllyniemi20002024-05-012024-05-17
Presence and Relapse Rates in Patients With Alcohol Use Disorder Using Virtual Reality
VR Cue-Exposure Therapy - Alcohol Dependence
CompletedCharite University, Berlin, Germany602024-04-012026-01-21
Neuromodulation and Mindfulness Patients With AUD
Transcutaneous vagus nerve stimulation, Closed-loop AM-tACS - Alcohol Dependence
Not applicableRecruitingCharite University, Berlin, Germany1402024-03-202026-03-20
Effects of Ketone Supplementation on Acute Alcohol Withdrawal
Kenetik; Ketone Concentrate, Isocaloric dextrose placebo - Alcohol Use Disorder, Alcohol Withdrawal
Phase 2 / Phase 3Enrolling by invitationUniversity of Pennsylvania502024-03-112026-04-06
Telehealth Treatment for Alcohol Use Disorder
Ria Treatment Platform - Alcohol Use Disorder, Alcohol Dependence
Not applicableActive not recruitingRia Health1352024-01-312026-06-30
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
Prolonged exposure therapy, MDMA, Niacin - PTSD, Alcohol Use Disorder
Phase 2UnknownUniversity of Sydney1202023-09-192023-11-07
Nitrate Modulates Cognitive Impairment Via Oral Microbiota.
nitrate-rich beetroot juice, nitrate-depleted beetroot juice - Microtia, Alcohol Dependence
Not applicableCompletedPeking University Sixth Hospital702023-09-102025-06-03
Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
Semaglutide Injectable Product, Placebo - Alcohol Abuse, Alcohol Addiction
Phase 2CompletedPsychiatric Centre Rigshospitalet1082023-06-132025-08-05
Study of the Neural Substrates of Alcohol Craving by High-resolution Electroencephalography
Induction of alcohol craving, Questionnaires - Alcoholism, Alcohol Dependence
Not applicableWithdrawnRennes University Hospital2023-05-012023-12-04

Showing 20 of 307. Sign in to see all of them.

Narrower conditions

Alcoholism (307)  ·  Substance-Related Disorders (38)  ·  Alcohol Drinking (22)  ·  Stress Disorders, Post-Traumatic (17)  ·  Alcohol-Related Disorders (16)  ·  Behavior, Addictive (15)  ·  Anxiety Disorders (12)  ·  Bipolar Disorder (11)  ·  Depression (10)  ·  Tobacco Use Disorder (9)  ·  Cocaine-Related Disorders (7)  ·  Mental Disorders (7)  ·  Schizophrenia (7)  ·  Mania (5)  ·  Psychotic Disorders (5)

Broader conditions

Chemically-Induced Disorders (305)  ·  Mental Disorders (300)  ·  Alcohol-Related Disorders (291)  ·  Substance-Related Disorders (269)  ·  Behavior (61)  ·  Drinking Behavior (23)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Trauma and Stressor Related Disorders (17)  ·  Nervous System Diseases (16)  ·  Stress Disorders, Traumatic (16)  ·  Compulsive Behavior (15)  ·  Impulsive Behavior (14)  ·  Mood Disorders (13)  ·  Pathologic Processes (12)  ·  Signs and Symptoms (12)

Interventions

Naltrexone (31)  ·  Ethanol (18)  ·  Topiramate (15)  ·  Sugars (14)  ·  Acamprosate (11)  ·  Cognitive Behavioral Therapy (11)  ·  nalmefene (11)  ·  vivitrol (11)  ·  Motivational Interviewing (10)  ·  Baclofen (7)  ·  Varenicline (7)  ·  Crisis Intervention (6)  ·  Gabapentin (6)  ·  Practice Management, Medical (5)  ·  Transcranial Magnetic Stimulation (5)

Sponsors

Yale University (22)  ·  National Institute on Alcohol Abuse and Alcoholism (NIAAA) (19)  ·  Medical University of South Carolina (18)  ·  University of Pennsylvania (7)  ·  Alkermes, Inc. (6)  ·  Charite University, Berlin, Germany (6)  ·  H. Lundbeck A/S (6)  ·  UConn Health (6)  ·  University of North Carolina, Chapel Hill (6)  ·  Boston Medical Center (5)  ·  NYU Langone Health (5)  ·  South West Sydney Local Health District (5)  ·  VA Office of Research and Development (5)  ·  Brown University (4)  ·  Centre for Addiction and Mental Health (4)

Countries

United States (196)  ·  France (18)  ·  Germany (16)  ·  Australia (8)  ·  Sweden (8)  ·  United Kingdom (6)  ·  Canada (4)  ·  Japan (4)  ·  Belgium (3)  ·  Denmark (3)  ·  Finland (3)  ·  India (3)  ·  Italy (3)  ·  Austria (2)  ·  Brazil (2)

Top investigators

Elizabeth Ralevski, Ph.D. (4)  ·  Ismene L Petrakis, MD (4)  ·  Ismene Petrakis, M.D. (4)  ·  Kirsten C Morley, PhD (4)  ·  Raymond F Anton, MD (4)  ·  Lorenzo Leggio, M.D. (3)  ·  Paul S Haber, MBBS (3)  ·  Steven L Batki, MD (3)  ·  Andrew Baillie, PhD (2)  ·  Bankole Johnson, DSc, MD, PhD (2)  ·  James C Garbutt, M.D. (2)  ·  James C Garbutt, MD (2)

Results publications

PMID 25227627, PMID 23873853, PMID 24190578, PMID 25832297, PMID 37142273, PMID 11153967, PMID 11468137, PMID 12637048, PMID 15908848, PMID 16012278, PMID 16129568, PMID 16300039, PMID 16905439, PMID 17113598, PMID 17283347, PMID 17663609, PMID 18614026, PMID 18636998, PMID 18819759, PMID 19309183, PMID 19560604, PMID 19593171, PMID 19593174, PMID 19926399, PMID 1992832, PMID 20331933, PMID 20363090, PMID 20402989, PMID 20921123, PMID 21124304, PMID 21389338, PMID 21454917, PMID 21491295, PMID 21620571, PMID 21631542, PMID 21631622, PMID 21787433, PMID 22234379, PMID 22234384, PMID 22480715, PMID 22551036, PMID 22651986, PMID 22722516, PMID 22954459, PMID 22985676, PMID 23131884, PMID 23134193, PMID 23218805, PMID 23237314, PMID 23276300

NIH funding

P60AA013759 (4), P50AA010761 (3), K01DA025073 (2), P60AA003510 (2), R01AA009568 (2), R01AA009892 (2), R37AA014028 (2), 1RC1AA019019-01 (1), 2009 (1), 2014 (1), 2018 (1), K23AA000222 (1), K23AA015616 (1), K23AA016340 (1), K23AA017508 (1)